[Retracted] Efficacy and Prediction Model Construction of Drug-Coated Balloon Combined with Cutting Balloon Angioplasty in the Treatment of Drug-Eluting Stent In-Stent Restenosis

Table 4

Univariate analysis of factors affecting the occurrence of DES-ISR.

Factors	ISR group ( =72)	Non-ISR group ( =59)	value	value
Age (years)	65.08 ± 5.38	64.34 ± 5.07	0.804	0.423
Gender (cases)
Male	42	35	0.013	0.909
Female	30	24
Abnormal BMI (cases)	43	20	8.663	0.003
Smoking (cases)	35	13	9.866	0.002
Hypertension (cases)	31	9	11.816	0.001
Diabetes (cases)	32	11	9.789	0.002
Hyperlipidemia (cases)	10	8	0.003	0.957
Family history of coronary heart disease (cases)	35	12	11.267	0.001
Platelets (10^11)	1.07 ± 0.19	1.13 ± 0.24	1.597	0.113
LVEF (%)	60.32 ± 5.09	59.83 ± 5.11	0.547	0.585
Number of arterial lesions (cases)
Multivessel lesions	61	29	19.081	<0.001
Single-vessel lesion	11	30
Target lesion location (cases)
Anterior descending branch	42	34	0.009	0.996
Circumflex branch	13	11
Right coronary artery	17	14
Stenosis target lesion degree (%)	88.34 ± 3.16	81.62 ± 3.86	10.958	<0.001
Target lesion diameter (mm)	2.85 ± 0.51	3.51 ± 0.59	6.866	<0.001
Target lesion length (mm)	41.69 ± 4.32	31.53 ± 5.04	12.422	<0.001
Stent implantation time (years)	4.07 ± 0.59	4.13 ± 0.67	0.545	0.587
Stent length (mm)	23.58 ± 2.73	21.09 ± 2.25	5.614	<0.001
Stent diameter (mm)	3.09 ± 0.18	3.26 ± 0.16	5.651	<0.001
Number of stents	1.95 ± 0.32	1.53 ± 0.21	8.665	<0.001
Postoperative medication (cases)
Statins	71	56	0.862	0.930
Beta-blockers	59	48
ACEI	37	34
ARB	18	11
Calcium channel blockers	30	25